Related Experiment Videos
Myocarditis as a prognostic indicator in systemic lupus erythematosus
S Busteed1, P Sparrow, C Molloy
1Department of Rheumatology, Royal Liverpool University Hospital, Liverpool, UK. sandra_busteed@hotmail.com
Postgraduate Medical Journal
|June 12, 2004
Summary
Lupus myocarditis, a severe complication of systemic lupus erythematosus (SLE), can cause heart failure. Treatment with cyclophosphamide and steroids resolved cardiac issues, but the patient later died from other causes.
Area of Science:
- Cardiology
- Rheumatology
- Immunology
Background:
- Systemic lupus erythematosus (SLE) is an autoimmune disease with potential multi-organ involvement.
- Lupus myocarditis is a rare but serious cardiac complication of SLE, often presenting with heart failure.
- Early diagnosis and management are crucial for improving outcomes in patients with SLE-related cardiac complications.
Observation:
- A case report details a patient with SLE who developed left ventricular failure.
- The cardiac failure was attributed to lupus myocarditis.
- The patient's cardiac symptoms improved with immunosuppressive therapy.
Findings:
- Treatment with pulsed cyclophosphamide and steroids effectively resolved the patient's cardiac failure.
- Despite successful cardiac management, the patient succumbed to non-cardiac complications 18 months post-diagnosis.
- This case highlights the complex and often fatal trajectory of severe SLE complications.
Implications:
- Aggressive immunosuppressive therapy can be effective in managing lupus myocarditis and associated cardiac dysfunction.
- Non-cardiac complications remain a significant cause of mortality in SLE patients, even after cardiac stabilization.
- Further research is needed to understand and mitigate long-term mortality risks in SLE.
- This case underscores the importance of a multidisciplinary approach to managing SLE patients with cardiac involvement.